The past year has seen significant advances in the epidemiology and management of thyroid cancer. This includes a better understanding of the increasing incidence of thyroid cancer worldwide, reclassification of a subtype of papillary thyroid cancer as non-invasive neoplasm, significant changes to TNM staging of thyroid cancer which take effect in 2018, and slow progress in understanding the genetic basis of familial nonmedullary thyroid cancer.